Proto-oncogene expression in human glomerular diseases

被引:1
|
作者
Takemura, T
Okada, M
Akano, N
Murakami, K
Hino, S
Yagi, K
Takekoshi, Y
Yoshioka, K
机构
[1] KINKI UNIV,SCH MED,DEPT PEDIAT,SAYAMA,OSAKA 589,JAPAN
[2] HOKKAIDO UNIV,SCH MED,DEPT PEDIAT,SAPPORO,HOKKAIDO 011,JAPAN
来源
JOURNAL OF PATHOLOGY | 1996年 / 178卷 / 03期
关键词
proto-oncogene; glomerulonephritis; proliferating cell nuclear antigen; mesangial cell;
D O I
10.1002/(SICI)1096-9896(199603)178:3<343::AID-PATH481>3.0.CO;2-H
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The expression of the protein products and mRNA of c-fos, c-myc, p53, and c-raf was examined in normal renal tissues and biopsy specimens from 73 patients with various glomerular diseases. Immunofluorescent staining showed that there were cell nuclei stained for c-Fos, c-Myc, and p53, and cytoplasm positive for c-Raf, in the glomeruli of patients with proliferative types of glomerulonephritis, including IgA nephritis and lupus nephritis, and in patients with focal glomerular sclerosis. Glomerular expression of c-fos and c-myc mRNA was detected by irt situ hybridization, The number of proto-oncogene-positive glomerular cells was significantly higher in lupus nephritis, IgA nephritis, and focal segmental sclerosis, as compared with minimal change nephrotic syndrome and normal specimens, In IgA nephritis, the population of glomerular cells positive for c-Fos and c-Myc and the grade of c-Raf immunoreactivity were significantly correlated with the proportion of proliferating cell nuclear antigen (PCNA)-positive glomerular cells, with histological grading of mesangial hypercellularity and matrix increase, and with the magnitude of proteinuria, These data indicate that proto-oncogene expression is associated with mesangial proliferation and matrix expansion in proliferative types of glomerulonephritis and in focal glomerular sclerosis.
引用
收藏
页码:343 / 351
页数:9
相关论文
共 50 条
  • [1] Expression of the RET proto-oncogene in human embryos
    Attié-Bitach, T
    Abitbol, M
    Gérard, M
    Delezoide, AL
    Augé, J
    Pelet, A
    Amiel, J
    Pachnis, V
    Munnich, A
    Lyonnet, S
    Vekemans, M
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1998, 80 (05): : 481 - 486
  • [2] HUMAN PROTO-ONCOGENE ASSIGNMENTS
    SAKAGUCHI, AY
    ZABEL, BU
    GRZESCHIK, KH
    LAW, ML
    NAYLOR, SL
    CYTOGENETICS AND CELL GENETICS, 1984, 37 (1-4): : 572 - 573
  • [3] INHIBITION OF PROTO-ONCOGENE EXPRESSION BY ETHANOL
    YASHIMA, T
    HAYASHI, N
    FURUSAWA, S
    KASAHARA, A
    SASAKI, Y
    MEREN, H
    FUSAMOTO, H
    SATO, N
    KAMADA, T
    ALCOHOL AND ALCOHOLISM, 1988, 23 (03): : A84 - A84
  • [4] EQUINE RAS PROTO-ONCOGENE EXPRESSION
    MADEWELL, BR
    GUMERLOCK, PH
    SAUNDERS, KA
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 1989, 50 (11) : 1990 - 1991
  • [5] Deregulated expression of the PCPH proto-oncogene in human breast cancers
    Blánquez, MJ
    Arenas, MI
    Conde, I
    Tirado, OM
    Paniagua, R
    Notario, V
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2004, 25 (04) : 821 - 830
  • [6] PROTO-ONCOGENE ABNORMALITIES IN HUMAN CANCER
    CLINE, MJ
    CLINICAL CHEMISTRY, 1989, 35 (06) : 1057 - 1057
  • [7] The RET proto-oncogene in human cancers
    Jhiang, SM
    ONCOGENE, 2000, 19 (49) : 5590 - 5597
  • [8] SPONTANEOUS ACTIVATION OF A HUMAN PROTO-ONCOGENE
    SANTOS, E
    REDDY, EP
    PULCIANI, S
    FELDMANN, RJ
    BARBACID, M
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (15): : 4679 - 4683
  • [9] The RET proto-oncogene in human cancers
    Sissy M Jhiang
    Oncogene, 2000, 19 : 5590 - 5597
  • [10] Cloning and expression of the axolotl proto-oncogene ski
    Ludolph, D. C.
    Neff, A. W.
    Parker, M. A.
    Mescher, A. L.
    B B A - Biomembranes, 1260 (01):